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Abstract
From time to time patients admitted with fever of unknown 
origin prove to be a diagnostic dilemma. While textbooks 
describe typical symptoms and signs, and also diagnostic tests, 
these are not always helpful. The following are two case reports 
of patients who were eventually diagnosed to be suffering from 
visceral leishmaniasis. It is apparent that the usual diagnostic 
tools at our disposal were not enough to identify the disease and 
new tests were needed. The case reports have some similarities; 
both patients are male, diabetic, resident in Gozo but not of 
Gozitan stock. These factors could have reduced their immunity 
to visceral leishmaniasis, making them more susceptible to the 
disease. 
Case history 
CB is a 60 year old male British resident in Gozo. He 
presented in March 2002 with a 2 month history of lethargy, 
reduced appetite, weight loss and fever. He is a diabetic on 
metformin and gliclazide, non-smoker and social drinker.
Examination revealed an ill-looking man with an oral 
temperature of 101.2 degrees Fahrenheit. He was very pale, 
and lethargic. His abdomen revealed hepatomegaly, palpable 
7cm below right costal margin and splenomegaly, palpable 
2cm below left costal margin. Rest of the examination was 
unremarkable; there was no rash and no lymph nodes were 
palpable. Initial investigations revealed blood glucose of 
23 mmol/L, haemoglobin of 5.1 g/dL, white blood count of 
2.5x103/µL,  platelets of 58x103 /µL. The patient was admitted to 
Gozo General Hospital and reverse barrier nursing was instituted. 
Several blood cultures were taken all of which eventually proved 
to have no growth. Imipenem 1g 8 hourly intravenously was 
started, with poor effect. Bone marrow aspirate was carried out, 
specifically asking for evidence of visceral leishmaniasis. This 
was also negative. Gastroscopy revealed small, non-bleeding 
varices with an H. pylori negative duodenitis. Abdominal 
ultrasound confirmed hepatosplenomegaly. The liver was 
coarse and had irregular echostructure. The splenic veins were 
tortuous. Ascites was present in the perihepatic and perisplenic 
regions. The patient was therefore also suffering from portal 
hypertertension. At this point the patient admitted to alcohol 
abuse especially in the past. Computerised Axial Tomography 
(CAT scan) of the chest was normal and that of the abdomen 
confirmed the ultrasound findings. Full infective screen 
including Brucella, Rickettsiae, Ebstein Barr, Hepatitis, HIV, 
and Leishmania antibodies were all negative. Liver function 
tests were deranged, with a mildly high bilirubin, and ALT, 
and with a high gamma GT. Over a period of 10 days the WBC 
fell to 1.4x103/µL, the platelets went down to 18x103/µL and his 
haemoglobin was 8.5g/dL. He was transfused with blood and 
platelets. At this point the patient expressed his wish to return 
back to the UK, which he did. While in his home country all the 
tests which were done locally were repeated including several 
bone marrow aspirates and trephine biopsies, all drawing a 
blank regarding diagnosis.  His fever did not settle, and he 
remained undiagnosed for a further 12 weeks. 
However the breakthrough came when the patient consulted 
another consultant in the UK who was convinced that, in spite 
of lack of evidence, this was a case of visceral leishmaniasis. A 
blood sample was sent to the Hospital for Tropical Diseases in 
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London  for assay of K39 antigen. This was found to be positive. 
The patient was started on liposomal amphotericin for 21 days, 
made a full recovery and came back to Gozo. He was reviewed 
last December and was well and asymptomatic with normal 
complete blood count. 
Case history  2
JG is a 50 year old male, diabetic Maltese living in Gozo for 
the past 10 years. He was admitted to Gozo General Hospital 
in June 2004 complaining of a 3 week history of fever (up to 
104 degrees Fahrenheit), rigors, and sweating. There was no 
obvious focus of infection i.e. no respiratory, urinary, or bowel 
symptoms. He did complain of mild frontal headache especially 
when febrile, but did not complain of weight loss or loss of 
appetite. He was on insulin, never traveled to exotic places, 
and kept pigeons at home.  He worked as ground crew with a 
local shipping line. 
On examination he was pale, weak, and had 104 degrees 
Fahrenheit temperature. He had long standing extensive 
vitiligo but no rashes, poor dental hygiene but a clear throat. 
His abdomen revealed splenomegaly, felt 5 cm below left costal 
margin. Initial investigation showed pancytopenia: white blood 
count 2.3x103/µL, haemoglobin 8.6g/dL, platelets 92x103/µL. 
The ALT and GGT were also elevated. Full infection screen 
was negative. Bone marrow aspirate and trephine biopsies did 
not show evidence of Leishmania Donovani bodies and were 
reported as normal. CAT scan of the abdomen was normal except 
for splenomegaly with no focal lesions. Repeated blood cultures 
did not show any growth. Leishmania antibodies were negative. 
The platelet count fell to 65x103/µL. At this point a diagnosis 
of lymphoproliferatvie/neoplastic disorder was suggested and 
the thought of splenectomy was entertained. However, based on 
experience of Case History 1 (above), K39 assay was requested 
and the patient’s blood samples were sent to the same hospital 
in London. The report came back as ‘Antibody to Leishmania 
K39 antigen POSITIVE.’ The patient was started on liposomal 
amphotericin intravenously for 21 days. The fever settled after 
4 days and the patient eventually left hospital healthy and 
asymptomatic. Subsequent follow-ups revealed a healthy patient 
with normal blood indices. 
Discussion
The diagnosis of visceral leishmaniasis (VL), a serious and 
often fatal parasitic disease caused by members of Leishmania 
donovani complex, remains problematic. Current methods rely 
on clinical criteria, parasite identification in aspirate material 
and serology. The latter methods use crude antigen preparations 
lacking in specificity. In fact in the case histories illustrated 
above, all the above-mentioned methods failed to clinch the 
diagnosis. The  patient in Case 2 had a more rapid diagnosis 
because of our experience with the first patient. 
The test which gave the diagnoses in both cases was the 
K39 assay. The blood samples of both patients were tested at 
the Hospital for Tropical Diseases, London. K39 represents 39 
amino acid repeats encoded by a kinesin-like gene of visceral 
leishmaniasis.  There are 2 methods how to test for K39:
1. Recombinant K39 dipstick method: One drop of the 
patent’s peripheral blood is applied to a nitrocellulose 
strip. 3 drops of test buffer (phosphate-buffered saline 
plus bovine serum albumin) are added to the dried blood. 
10 minutes later the test area is observed. Two visible 
bands confirm the presence of IgG anti-K39. This test is 
much like the usual home pregnancy test kit, here a single 
band indicates a valid but negative test while 2 bands 
indicate a valid and positive test. 
2.  Recombinant K39 ELISA: This is an enzyme linked 
immunosorbent assay for IgM and IgG for K39. 
The method used by the Hospital for Tropical Diseases 
in both patients was the dipstick method (John Bligh, Senior 
Biomedical Scientist, Hospital for Tropical Diseases, personal 
communication). 
Comparison of K9 dipstick test 
to other methods
Several studies have been carried out to assess sensitivity 
and specificity of this test, and especially how it compares to 
other methods. Sundar et al1 and Goswami  et al2  found 100 
percent sensitivity and 98 percent specificity in 2 separate and 
independent studies. When compared to the ELISA method, 
rK39 dipstick had 90% sensitivity compared to 89% for ELISA. 
The latter was 98% specific while rK39 was 100%.3 ELISA was 
found to be valuable in monitoring drug therapy and detecting 
relapse of the disease.4 
The dipstick method for rK39 was also compared to Direct 
Agglutinin Titration (DAT). While DAT had a sensitivity of 
99% and specificity of 82%, rK39 was 97% sensitive and 71% 
specific.5  This was a study in Nepal and the authors suggested 
that the dipstick test in this area should be used for screening 
suspect patients in endemic areas. The use of the dipstick tests 
as confirmatory methods should be restricted to situations 
where the proportion of Kala-azar among clinically suspect 
patients is high. This was confirmed by Igbal et al.6 Another 
study comparing DAT with rK39 carried out in the Netherlands7 
confirmed that DAT was superior and more specific than the 
dipstick rK39 test but the latter was more rapid, more user 
friendly and cheaper. The advantageous practical and economic 
aspects of the rK39 dipstick method were confirmed by another 
study  in Nepal.8 Burns et al9 even suggest using rK39 instead 
of all other serological tests for VL. 
Apart from its use in diagnosing VL, the dipstick rK39 test 
has also been found to be effective to differentiate American VL 
from other endemic diseases in Venezuela.10  
Canine infections with Leishmania infantum are important 
as a cause of serious disease in the dog, and as a reservoir for 
human VL. Accurate infection is essential to the veterinary 
community and for VL surveillance programs. Testing for rK39 
in the field has been proposed as a relatively fast, reliable and 
simple test for assessing infection of dogs.11 
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Conclusion
As illustrated by the case histories above, the rK39 test 
should be considered in any patient who fits the clinical 
criteria for visceral leishmaniasis, but where the usual tests 
have been repeatedly negative. To date, the simple dipstick test 
for rK39 is not available in the Maltese islands, neither in the 
public laboratories nor in the private sector. Given the above 
information, maybe it is time to change this state of affairs.  
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